SEOUL, South Korea, July 17, 2025 /PRNewswire/ -- DeepQure announced today that South Korea's Ministry of Food and Drug Safety (MFDS) has approved a clinical trial of HyperQure™ RDM System, the company's novel laparoscopic renal denervation (RDN) system, for the treatment of atrial...
Hence then, the article about mfds clears deepqure s hyperqure for clinical trial in atrial fibrillation was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( MFDS Clears DeepQure's HyperQure™ for Clinical Trial in Atrial Fibrillation )
Also on site :
- Retired Gen. Wesley Clark tangled up in a crypto fraud suit with Burning Man buddies
- My Friend Invited Us for Dinner. When She Greeted Us at the Door, She Asked for Something Shocking.
- Iconic '80s Boy Band Impresses With 'Amazing' Live Performance